Advanced technology. Exacting standards.

Company Overview

Implant Sciences Corporation (IMSC:OTCBB) develops and commercializes explosives trace detection (ETD) solutions for transportation, critical infrastructure, and ports and borders security, as well as force protection and emergency response.

Founded in 1984, Implant Sciences has a rich history of developing leading technologies in several markets including: ion implantation services for the semiconductor industry; brachytherapy seeds for prostate cancer treatment; and sophisticated coatings to reduce wear on orthopedic joint replacements.

By the end of 2008, as part of the company’s restructuring towards a single business focus, the medical and semiconductor businesses and associated assets were fully divested. The company today is a pure play in global Security, Safety, and Defense (SS&D) markets.